Bangladesh Beximco Starts Drugs Exports to Jordan (Bangladesh)
This article was originally published in PharmAsia News
Executive Summary
Bangladesh's top drug maker, Beximco Pharmaceuticals announced Sept. 30 that it will soon begin exporting medicines to Jordan. So far, Beximco has received approval for four different treatments, with several other applications in the works. Jordan has a pharmaceutical market worth an estimated $315 million that primarily relies on imports. The country also boasts a strong infrastructure, a well-regulated healthcare system, and strong trading partnerships throughout the Middle East. Representatives for Beximco say these factors make the country an ideal entry point for the company into the region's markets. (Click here for more
You may also be interested in...
EU Health Ministers To Deliberate Over Commission’s Pharma Strategy
A package of health proposals intended to build up the EU’s resilience to health threats while strengthening the competitiveness of Europe’s pharmaceutical industry and ensuring access to affordable drugs takes a major step through the legislative process this week.
Latest Vascepa Lawsuit Plunges Hikma Into Induced Infringement Battle
Hikma has pushed back against a further attempt by Amarin to counter its US generic version of Vascepa, this time via a fresh lawsuit claiming that the generic induces infringement of patents protecting cardiovascular indications for which the brand is approved but which are carved out of the generic label.
EU Approval Of COVID-19 Vaccines Possible In Weeks
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.
Need a specific report? 1000+ reports available
Buy Reports